A concurrent resolution condemning Russia's unjust and arbitrary detention of Russian opposition leader Vladimir Kara-Murza who has stood up in defense of democracy, the rule of law, and free and fair elections in Russia.
Legislative Progress
Introduced
March 23, 2023
Latest Action
November 6, 2023
Primary Sponsor
Benjamin L. CardinDemocratic(MD)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
228d open
vs 46 other SCONRES bills in the 118th — cohort avg 21d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2025 · first_quarter · Tobacco
Lobbying Report: January 1st - March 31st, 2025 (Action Fund) Federal (under tobacco issue code) Legislation: S. 4690/H.R. 9027 (118th Congress) - FY 25 Agriculture, Rural Development, and Food and Drug Administration, and Related Agencies Appropriations Bill S. 4942/H.R. 9029 (118th Congress) - FY 25 Labor, HHS, Education, and Related Agencies Appropriations Bill Tobacco User Fee Modernization Act Stop Chinese Vapes from Poisoning American Kids Act H.R. 1798/S. 819 End Tobacco Loopholes Act H.R. 1968 - FY2025 Full-Year Continuing Appropriations and Extensions Act FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Bill FY 26 Labor Health and Human Services, Education, and Related Agencies Appropriations Act Preventing Opportunities for Teen E-cigarette and Tobacco Addiction (PROTECT) Act S.Con.Res.7 - Senate Budget Resolution Issues FDA regulation of e-cigarettes FDA nicotine standard FDA tobacco user fees Youth e-cigarette use CDC Office on Smoking and Health funding Congressional efforts to reduce e-cigarette and tobacco use FDA rule on menthol cigarettes FDA rule on flavored cigars Department of Health and Human Services Reorganization FDA Authority over tobacco products Senate budget resolution Prevention and Public Health Fund WHO Withdrawal Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration
Held at the desk.
Received in the House.
Message on Senate action sent to the House.
The committee amendment to the preamble withdrawn by Unanimous Consent.
Resolution agreed to in Senate with an amendment and an amended preamble by Unanimous Consent.
Passed/agreed to in Senate: Resolution agreed to in Senate with an amendment and an amended preamble by Unanimous Consent.
The committee substitute withdrawn by Unanimous Consent.
Measure laid before Senate by unanimous consent.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 52.
Committee on Foreign Relations. Reported by Senator Menendez with an amendment in the nature of a substitute and with an amended preamble. Without written report.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $380,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Tobacco
Federal (under tobacco issue code) Legislation: S. 4690/H.R. 9027 (118th Congress) - FY 25 Agriculture, Rural Development, and Food and Drug Administration, and Related Agencies Appropriations Bill S. 4942/H.R. 9029 (118th Congress) - FY 25 Labor, HHS, Education, and Related Agencies Appropriations Bill Tobacco User Fee Modernization Act Stop Chinese Vapes from Poisoning American Kids Act H.R. 1798/S. 819 End Tobacco Loopholes Act H.R. 1968 - FY2025 Full-Year Continuing Appropriations and Extensions Act FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Bill FY 26 Labor Health and Human Services, Education, and Related Agencies Appropriations Act Preventing Opportunities for Teen E-cigarette and Tobacco Addiction (PROTECT) Act S.Con.Res.7 - Senate Budget Resolution Issues FDA regulation of e-cigarettes FDA nicotine standard FDA tobacco user fees Youth e-cigarette use CDC Office on Smoking and Health funding Congressional efforts to reduce e-cigarette and tobacco use FDA rule on menthol cigarettes FDA rule on flavored cigars Department of Health and Human Services Reorganization FDA Authority over tobacco products Senate budget resolution Prevention and Public Health Fund WHO Withdrawal
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Health Issues
H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034, provisions related to recommendations of changes in laws within the jurisdiction of the Senate Finance Committee and House Energy and Commerce Committee S.Con.Res.7- An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034, provisions related to the recommendations of changes in laws within the jurisdiction of the Senate Finance Committee and House Energy and Commerce Committee H.R. 869/S.343, Keep Our PACT Act, all provisions H.R. 1436/S.627, ENABLE Act, all provisions H.R. 1520, CharlotteWoodwardOrgan Transplant Discrimination Prevention Act, all provisions H.R. 1570/S.745, EmpoweringFamiliesin Special Education Act, all provisions H.R. 1621, Entrepreneurs with Disabilities Reporting Act of 2025, all provisions H.R. 1634, ThinkDIFFERENTLY About Disability Employment Act, all provisions H.R. 1757/S.73, EMPSA Act, all provisions H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025, provision related to funding of the congressionally directed medical research program H.R. 2036/S. 925, CreditforCaring Act of 2025, all provisions H.R. 2491/S.1227, ABC Act, all provisions H.R. 2540/S.1234, SSI Savings Penalty Elimination Act, all provisions H.R. 2560/S.830, Lifespan Respite Care Reauthorization Act of 2025, all provisions H.R. 2598/S.1277, IDEA Full Funding Act, all provisions Implementation of Public Law 118-80, Autism CARES Act of 2024, all provisions A bill not yet introduced to enhance incentives to create accessible and inclusive workplaces A bill not yet introduced to increase housing opportunities for people with disabilities A reconciliation bill not yet introduced, provisions related to Medicaid A bill not introduced related to Fiscal Year 2026 appropriations by the House, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration; assistive technology programs and special education at the Department of Education; funding for the Kevin and Avonte's Law Program; and the congressionally directed medical research autism research program A bill not introduced related to Fiscal Year 2026 appropriations by the Senate, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration; assistive technology programs and special education at the Department of Education; funding for the Kevin and Avonte's Law Program; and the congressionally directed medical research autism research program A bill not yet introduced to designate individuals with intellectual and developmental disabilities as a medically underserved population
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Medicare/Medicaid
Medicare Advantage (MA) Policy and Reimbursement Enactment of policies in Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Calendar Year (CY) 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F) Implementation of CMS Interoperability and Prior Authorization final rule (CMS-0057-F) Calendar Year (CY) 2025 Home Health Prospective Payment System Final Rule (CMS-1803-F) Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F) Announcement of Calendar Year (CY) 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Final Calendar Year (CY) 2025 Part D Redesign Program Instructions Fiscal Year (FY) 2025 Hospice Payment Rate Update Final Rule (CMS-1810-F) Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-P) Calendar Year (CY) 2026 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 S.Con.Res.7, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034
Client expense: $2,510,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Committee on Foreign Relations. Ordered to be reported with amendments favorably.
Referred to the Committee on Foreign Relations. (text: CR S939)
Introduced in Senate
| Republican |
| IA |
| Edward J. Markey | Democratic | MA |
| James E. Risch | Republican | ID |
| John W. Hickenlooper | Democratic | CO |
| Marco Rubio | Republican | FL |
| Patty Murray | Democratic | WA |
| Pete Ricketts | Republican | NE |
| Richard J. Durbin | Democratic | IL |
| Robert Menendez | Democratic | NJ |
| Roger F. Wicker | Republican | MS |
| Sheldon Whitehouse | Democratic | RI |
| Tim Kaine | Democratic | VA |